4910-04-7Relevant academic research and scientific papers
Synthesis of differently substituted tacn-based ligands: Towards the control of solubility and electronic and steric properties of uranium coordination complexes
Nizovtsev, Alexey V.,Scheurer, Andreas,Kosog, Boris,Heinemann, Frank W.,Meyer, Karsten
, p. 2538 - 2548 (2013/07/11)
Starting from phenols R1,R2ArOH (5) and the anisole derivative 3,5-di-tert-butyl-2-methoxybenzyl bromide (13), a series of new tacn-based ligands (R1,R2ArOR3)3tacn (2) have been synthesized with substituents of
HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS
-
Paragraph 1399-1401, (2013/10/22)
The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS
-
Page/Page column 226-227, (2012/06/30)
The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
IMIDAZOLIDINEDIONE DERIVATIVES
-
Page/Page column 82-83, (2011/06/26)
The invention provides a compound of formula (Ia), and pharmaceutically acceptable salts thereof. The invention also provides use of the compounds or salts as modulators of Kv3.1 and/or Kv3.2, and in the treatment of diseases or disorders where a modulator of Kv3.1 and/or Kv3.2 is required, such as depression and mood disorders, hearing disorders, schizopherenea, substance abuse disorders, sleep disorders or epilepsy.
Isoreticular chiral metal-organic frameworks for asymmetric alkene epoxidation: Tuning catalytic activity by controlling framework catenation and varying open channel sizes
Song, Feijie,Wang, Cheng,Falkowski, Joseph M.,Ma, Liqing,Lin, Wenbin
supporting information; experimental part, p. 15390 - 15398 (2011/01/10)
A family of isoreticular chiral metal-organic frameworks (CMOFs) of the primitive cubic network topology was constructed from [Zn4(μ 4-O)(O2CR)6] secondary building units and systematically elongated dicarboxyla
PYRROLIDINE-2-CARBONITRILE DERIVATIVES AND THEIR USE AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV)
-
Page/Page column 103, (2008/06/13)
The present invention relates to compounds of formula (I), (I), which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, syndrome X, hyperinsulinemia, b-cell failure, obesity, satiety disorders, atherosclerosis, and various immunomodulatory diseases.
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
-
Page/Page column 47, (2010/02/12)
The present invention relates to compounds of formula (I), which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, syndrome X, hyperinsulinemia, β-cell failure, obesity, satiety disorders, atherosclerosis, and various immunomodulatory diseases.
